4//SEC Filing
McHale Duncan 4
Accession 0001694665-23-000154
CIK 0001694665other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 8:54 PM ET
Size
5.5 KB
Accession
0001694665-23-000154
Insider Transaction Report
Form 4
McHale Duncan
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2023-09-11+37,500→ 37,500 total→ Common Stock (37,500 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vest in three (3) substantially equal installments on each of November 1, 2023, February 1, 2024 and May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. These RSUs have no expiration date.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001738896
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 8:54 PM ET
- Size
- 5.5 KB